Risperidone as an adjunct to valproic acid
Waring, E.W.; Dewan, V.K.; Cohen, D.; Grewal, R.
Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(2): 189
1999
ISSN/ISBN: 0706-7437 PMID: 10097843 Document Number: 503742
Document emailed within 1 workday
Related Documents
Henderson, D.C.; Goff, D.C. 1996: Risperidone as an adjunct to clozapine therapy in chronic schizophrenics Journal of Clinical Psychiatry 57(9): 395-397Porubek, D.J.; Grillo, M.P.; Baillie, T.A. 1989: The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(2): 123-130
Champel, V.; Radal, M.; Moulin-Vallez, M.; Jonville-Béra, A.P.; Autret-Leca, E. 1999: Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy Revue Neurologique (Paris) 155(3): 220-224
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Kohda, Y. 1995: Valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 918-920
Gedan, A.; Kleemann, V.; Pfeifer, S. 1984: Hydrolysis of valproamide to valproic acid Die Pharmazie 39(12): 865
Klotz, U. 1977: Pharmacokinetic studies with valproic acid in man Arzneimittel-Forschung 27(5): 1085-1088
Borchert, H.H.; Schuster, S.; Pfeifer, S. 1980: Metabolic interaction of valproic acid Die Pharmazie 34(5-6): 313-314
Borison, R.L. 1996: Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing Clinical Therapeutics 18(4): 592-607; discussion 591
Van Woert, M.H.; Chung, E.Y. 1986: Possible mechanisms of action of valproic acid in myoclonus Advances in Neurology 43: 653-660
Bruni, J.; Wilder, B.J.; Willmore, L.J.; Barbour, B. 1979: Valproic acid and plasma levels of phenytoin Neurology 29(6): 904-905
Kohda, Y. 1990: Therapeutic drug monitoring of valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1130-1133
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
Löscher, W. 1981: Anticonvulsant activity of metabolites of valproic acid Archives Internationales de Pharmacodynamie et de Therapie 249(1): 158-163
Vajda, F.J. 1983: Valproic acid in the treatment of status epilepticus Advances in Neurology 34: 519-529
Tonnelier, J.M.; Mocquard, Y.; Broch, C.; Vandhuick, O.; Goas, P.; Goas, J.Y. 2001: Febrile pleuropericarditis during valproic acid treatment Presse Medicale 30(2): 62-63
Michaelis, M.; Doerr, H.W.; Cinatl, J. 2007: Valproic acid as anti-cancer drug Current Pharmaceutical Design 13(33): 3378-3393
Goudie, J.H.; Reed, K.; Ayers, G.J.; Burnett, D. 1980: Improved extraction of valproic acid from serum before chromatography Clinical Chemistry 26(13): 1929
Blicher, T.M.; Vestergaard, E.T.; Dalhoff, K.P. 2012: The clinical course of a three year-old girl after overdose of valproic acid Ugeskrift for Laeger 174(17): 1165-1166
Sorel, L.; Rucquoy-Ponsar, M.; Willems, C.; Diepart, E.; Harmant, J. 1981: Comparative study of valproic acid and sodium valproate Acta Neurologica Belgica 81(5): 283-290